Anti-cancer therapies
US9205098B2 · kind B2 · utility
1Cited by
4References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 23, 2012 |
| Grant date | Dec 8, 2015 |
| Priority date | — |
| Expiry date | Jan 20, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the treatment of cancer are described. In particular, methods for treatment of cancer comprising administration of glufosfamide alone or in combination with another anticancer agent are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.